Dow Up 0.12% Nasdaq Up 1.35%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
8.04 Down 0.22(2.60%) 4:00PM EDT
|After Hours : 8.03 Down 0.01 (0.12%) 6:13PM EDT - Nasdaq Real Time Price
Prev Close:8.26
Open:8.21
Bid:7.84 x 100
Ask:8.03 x 200
1y Target Est:7.67
Beta:0.65
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:7.89 - 8.25
52wk Range:7.22 - 10.26
Volume:2,286,642
Avg Vol (3m):3,162,920
Market Cap:1.29B
P/E (ttm):4.86
EPS (ttm):1.65
Div & Yield:0.60 (7.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIDown 2.60%1.29B
AMGNUp 2.86%104.45B
SGENUp 1.73%4.35B
XOMAUp 5.59%455.08M

Key Statistics

Forward P/E (1 yr):3.32
P/S (ttm):3.02
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.20
Quarterly EPS Est (Sep-14) :0.61
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.26

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback